Back

Chronic cocaine exposure negatively impacts Long-COVID-like outcomes produced by the SARS-CoV-2 spike protein in the rat

Davis, S. E.; Stern, D. R.; Inan, S.; Vu, E.; Lopez, D.; Anwuri, F.; Ghilotti, M. G.; Meissler, J. J.; Unterwald, E. M.

2026-06-02 neuroscience
10.64898/2026.06.02.729575 bioRxiv
Show abstract

Acute COVID-19 outcomes are exacerbated by substance use, however, the impact of substance use on Long-COVID is unknown. Here, we investigated the impact of chronic cocaine administration on spike-induced Long-COVID-like outcomes in the rat. Rats received intermittent chronic cocaine administration and a single intravenous injection of the SARS-CoV-2 spike protein. Two months following spike administration, Long-COVID-like outcomes were assessed. Exposure to spike protein in the presence of cocaine produced a persistent reduction in weight gain as compared with controls or spike protein alone. Further, cocaine-treated rats exposed to spike had lower withdrawal thresholds compared to control animals as well as their own baseline, suggesting increased pain sensitivity. Spike and/or cocaine increased the ratio of interleukin-6 (IL-6) to interleukin-10 (IL-10) levels in the hippocampus, indicating a shift towards a proinflammatory state. Paw withdrawal thresholds were positively correlated with IL-10 levels in the hippocampus and prefrontal cortex. Regarding olfaction, rats exposed to spike spent less time sniffing an odor attractant. Cocaine produced an anxiolytic-like phenotype during the elevated plus maze test. Further analysis of behaviors on the maze revealed that the latency to enter the open arms was shorter in rats exposed to spike or cocaine, suggesting a possible impulsive-like phenotype in these animals. These findings demonstrate the negative impact of cocaine on Long-COVID-like outcomes suggesting a need for increased clinical observations of people with co-occurring Long-COVID and cocaine use disorder. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=59 SRC="FIGDIR/small/729575v1_ufig1.gif" ALT="Figure 1"> View larger version (10K): org.highwire.dtl.DTLVardef@12fdc19org.highwire.dtl.DTLVardef@11b1b0dorg.highwire.dtl.DTLVardef@8d1e21org.highwire.dtl.DTLVardef@b53d20_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Addiction Biology
47 papers in training set
Top 0.1%
17.5%
2
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
8.4%
3
Psychopharmacology
59 papers in training set
Top 0.1%
7.2%
4
Addiction Neuroscience
17 papers in training set
Top 0.1%
6.8%
5
Neuropsychopharmacology
134 papers in training set
Top 0.5%
6.3%
6
Translational Psychiatry
219 papers in training set
Top 1%
4.8%
50% of probability mass above
7
Drug and Alcohol Dependence
37 papers in training set
Top 0.3%
3.7%
8
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.1%
3.6%
9
Frontiers in Behavioral Neuroscience
46 papers in training set
Top 0.2%
3.6%
10
Scientific Reports
3102 papers in training set
Top 41%
3.1%
11
Neuropharmacology
60 papers in training set
Top 0.4%
2.1%
12
Frontiers in Psychiatry
83 papers in training set
Top 2%
2.1%
13
eneuro
389 papers in training set
Top 5%
1.9%
14
Journal of Psychopharmacology
14 papers in training set
Top 0.2%
1.7%
15
Psychological Medicine
74 papers in training set
Top 1.0%
1.7%
16
PLOS ONE
4510 papers in training set
Top 58%
1.3%
17
British Journal of Pharmacology
34 papers in training set
Top 0.3%
1.3%
18
European Journal of Neuroscience
168 papers in training set
Top 0.9%
1.1%
19
ACS Chemical Neuroscience
60 papers in training set
Top 2%
0.9%
20
Pain
70 papers in training set
Top 0.7%
0.9%
21
Behavioural Brain Research
70 papers in training set
Top 0.9%
0.9%
22
Biological Psychiatry
119 papers in training set
Top 2%
0.8%
23
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
0.8%
24
European Neuropsychopharmacology
15 papers in training set
Top 0.5%
0.8%
25
Schizophrenia Research
29 papers in training set
Top 0.6%
0.7%
26
Neuroscience
88 papers in training set
Top 3%
0.7%
27
Biological Psychiatry Global Open Science
54 papers in training set
Top 2%
0.7%
28
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.3%
0.6%
29
Molecular Psychiatry
242 papers in training set
Top 4%
0.6%